When audit- and feedback is proven effective in improving the quality of care in dementia, our findings may be implemented on a larger scale, along with specific recommendations for effective implementation of audit- and feedback in nursing homes. Competing interests The authors declare that they have no competing interests. Authors’ contributions All authors have made substantial contributions to conception and design of the study. JAB, MvS-P, HCWdV and JTvdS have drafted the manuscript. All authors have revised it critically for important intellectual content and have given final approval of the version to be published. Pre-publication history

Inhibitors,research,lifescience,medical The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1472-684X/12/29/prepub Acknowledgment We thank Dr. Dinnus H.M. Frijters for his contribution to the development of the feedback program. Funding This study is supported Inhibitors,research,lifescience,medical by a grant from ZonMw, The Netherlands Organisation for Health Research and Development (Palliative Care in the Terminal Phase program, a supplement for implementation to grant number 1150.0003), Inhibitors,research,lifescience,medical and Fonds

NutsOhra, national insurance company (grant number 0904–020), and by the VU University Medical Center, EMGO Institute for Health and Care Research, Department of General Practice & Elderly Care Medicine, Amsterdam. The Netherlands National Trial Register (NTR). Trial number: NTR3942. This registry shares selleckchem registered trials with WHO’s International Clinical Inhibitors,research,lifescience,medical Trials Registry Platform Search Portal: http://apps.who.int/trialsearch/. Previous publications Abstract submitted to the annual congress of Alzheimer Europe in October 2012. The abstract

is available on the internet site of Alzheimer Europe.
Population-based mortality follow-back designs used to survey a cohort of decedents’ next-of-kin or Inhibitors,research,lifescience,medical informal caregivers about end-of-life care (EOLC) have been employed in the UK, the US and Italy [1-7]. This approach permits representative sampling of a population of decedents and helps address several sources of bias encountered in prospective designs such as the identification of people who are at end of life in a specific time period, the recruitment of both recipients and non-recipients of services and the non-participation, Anacetrapib withdrawal or http://www.selleckchem.com/products/Tipifarnib(R115777).html ethical exclusion of those too ill to participate [2,8,9]. Follow-back studies are viewed as an essential strategy in describing the events around death [10-12]. Such studies, Teno argues, are among the “multiple methods (or strategies), either combined or in sequence, needed to examine a complex, multidimensional phenomenon such as end-of-life care” [8]. Population-based mortality follow-back surveys have efficiently collected data from bereaved family members (informants) on a range of variables that are not available in administrative data, thus providing population-based estimates on EOLC that otherwise would be unattainable [8].